These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9862600)

  • 1. Getting stoned without inhaling: anandamide is the brain's natural marijuana.
    Stahl SM
    J Clin Psychiatry; 1998 Nov; 59(11):566-7. PubMed ID: 9862600
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoid antagonists: a treatment in search of an illness.
    D'Souza DC; Kosten TR
    Arch Gen Psychiatry; 2001 Apr; 58(4):330-1. PubMed ID: 11296092
    [No Abstract]   [Full Text] [Related]  

  • 3. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM; Kirkham TC
    Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors.
    Ugdyzhekova DS; Bernatskaya NA; Stefano JB; Graier VF; Tam SW; Mekhoulam R
    Bull Exp Biol Med; 2001 Mar; 131(3):251-3. PubMed ID: 11427912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of anandamide hypotension by the transport inhibitor, AM404.
    Calignano A; La Rana G; Beltramo M; Makriyannis A; Piomelli D
    Eur J Pharmacol; 1997 Oct; 337(1):R1-2. PubMed ID: 9389389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and endogenous cannabinoid systems.
    Childers SR; Breivogel CS
    Drug Alcohol Depend; 1998; 51(1-2):173-87. PubMed ID: 9716939
    [No Abstract]   [Full Text] [Related]  

  • 8. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
    Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.
    Wallace MJ; Martin BR; DeLorenzo RJ
    Eur J Pharmacol; 2002 Oct; 452(3):295-301. PubMed ID: 12359270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
    Mallet PE; Beninger RJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
    Huestis MA; Gorelick DA; Heishman SJ; Preston KL; Nelson RA; Moolchan ET; Frank RA
    Arch Gen Psychiatry; 2001 Apr; 58(4):322-8. PubMed ID: 11296091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
    Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
    Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats.
    Smith FL; Fujimori K; Lowe J; Welch SP
    Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors and their endogenous agonist, anandamide.
    Axelrod J; Felder CC
    Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK; Alexander SP; Boyd EA; Kendall DA
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenously produced cannabinoids and liver cirrhosis.
    Senior K
    Lancet; 2001 Jul; 358(9275):42. PubMed ID: 11454385
    [No Abstract]   [Full Text] [Related]  

  • 20. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
    Farquhar-Smith WP; Jaggar SI; Rice AS
    Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.